ArticleFrontiers in endocrinology2025
Association of wrist circumference with metabolic dysfunction associated fatty liver disease in the KADEM cohort.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic dysfunction-associated fatty liver disease exacerbates hematoma expansion in intracerebral hemorrhage: an explainable machine learning approach.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early detection of individuals at high risk of MAFLD is essential for timely interventions. This study explores the association between wrist circumference and MAFLD among participants in the Kuwait Adult Diabetes and Epidemiological Multidisciplinary (KADEM) program, aiming to evaluate wrist circumference as a potential noninvasive diagnostic marker. Materials and methods: This study included 449 participants assessed for MAFLD using FibroScan Results: The cohort included 184 (41.5%) normal, 77 (17.4%) S1, 81 (18.3%) S2, and 101 (22.8%) S3 participants. Wrist circumference was significantly different across groups: 16 cm for normal, 17 cm for S1 and S2, and 17.2 cm for S3 ( Conclusion: Wrist circumference is a potential noninvasive marker for the identification of individuals at high risk of MAFLD, representing a cost-effective screening tool for early detection. Further research is needed to confirm its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.